GSK's RSV, Shingles vaccines show on-par immune response in joint trial
(Reuters) -British drugmaker GSK said on Wednesday administration of its respiratory syncytial virus (RSV) vaccine and shingles shot together generated the same immune response in a late-stage trial as separate adminstration of the vaccines.
GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults
GSK released data from a Phase 3 trial evaluating the co-administration of Arexvy and Shingrix vaccines in adults 50+. The study showed a non-inferior immune response and good safety profiles. The results will support regulatory submissions to the FDA and EMA.
GSK Reports Positive Data From Co-administration Of RSV And Shingles Vaccines
GSK plc (GSK, GSK.L) announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the
GSK Meets Study Goal for Co-Administered RSV-Shingles Vaccines
GSK plc GSK announced positive topline results from a phase III study evaluating the co-administration of its two marketed vaccines — RSV vaccine Arexvy and shingles vaccine Shingrix — in older adults (aged 50 years and older).
GSK posts late-stage trial win for co-administered RSV and shingles vaccines
GSK (NYSE:GSK) announced Wednesday that its Arexvy vaccine for respiratory syncytial virus (RSV) and its Shingrix vaccine for shingles reached the main goal in a Phase 3 trial when they were co-administered in adults aged 50 and older.
Low oxygen levels in tumors could enhance some of the body's immune responses against cancer
In the complex landscape of cancer, tumors create their own microenvironment, often marked by low oxygen levels, a condition ...
Science Media Centre1d
Young children have a different immune response to COVID – Expert Reaction
Children under 5 years old have a weaker immune response to COVID-19 compared with older children and adults, new research ...
Talk Business1d
UAMS receives $2.2 million grant to study immune response to eye disease
The University of Arkansas for Medical Sciences (UAMS) received a five-year $2,195,685 federal grant to study how modulating ...
News Medical on MSN2d
Long COVID patients maintain robust immune memory two years after infection
Researchers discovered that SARS-CoV-2-specific T and B cells in long COVID patients are maintained for two years, similar to ...
earth11d
How do deadly molds attack the immune system of humans?
Study identified glycosylasparaginase on Aspergillus fumigatus spores. This enzyme weakens immunity, allowing the mold to ...
Team demonstrates unprecedented control of SIV replication with immune-based approach
Emory researchers are the first to show unprecedented control of SIV replication and decay of viral reservoirs by combining a ...
Science Daily2d
Cancer cells may be using lipids to hide from the immune system
New study demonstrates that one type of lipid is so critical for immune evasion that certain cancers cannot proliferate without them. Modulating intake of dietary lipids could open up an avenue for ...
News Medical on MSN13h
Immune proteins in tooth enamel provide clues about ancient human health
A new way of looking at tooth enamel could give scientists a path to deeper understanding of the health of human populations, from the ancient to the modern.
The EMBO Journal2d
Acetylation of TIR domains in the TLR4-Mal-MyD88 complex regulates immune responses in sepsis
Activation of macrophage TLR4 by bacterial endotoxins is important for the progression of sepsis, but the underlying ...
NZ Doctor1d
Young children have a different immune response to COVID
An in-depth study of adaptive immune response to SARS-CoV-2 infection concludes that children under 5 years old have a different response compared with older children and adults. The findings make it ...